Evidence that 8-methoxypsoralen (8-MOP) is a T-lymphocyte immunomodulatory agent
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (6) , 773-781
- https://doi.org/10.1016/0192-0561(88)90031-8
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptorsNature, 1987
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- 8-methoxypsoralen inhibits lymphocyte proliferation in vitro in the absence of ultraviolet radiationInternational Journal of Immunopharmacology, 1987
- Psoralens Increase the Concentration of Cyclic AMP in Human Cells In VitroJournal of Investigative Dermatology, 1985
- Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.The Journal of Experimental Medicine, 1984
- Agents that increase cellular cAMP inhibit production of interleukin-2, but not its activityBiochemical and Biophysical Research Communications, 1983
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- PHOTOCHEMISTRY AND PHOTOBIOLOGY OF PSORALENSPhotochemistry and Photobiology, 1979
- Oral photochemotherapy in the treatment of lichen planus (LP).British Journal of Dermatology, 1978
- Role of Cyclic Nucleotides in Growth ControlAnnual Review of Biochemistry, 1975